- Home
- IRMD vs ASTH Comparison
IRMD vs ASTH Comparison
Compare IRMD & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- ASTH
- Stock Information
- Founded
- IRMD 1992
- ASTH 1994
- Country
- IRMD United States
- ASTH United States
- Employees
- IRMD N/A
- ASTH N/A
- Industry
- IRMD Medical/Dental Instruments
- ASTH Professional Services
- Sector
- IRMD Health Care
- ASTH Consumer Discretionary
- Exchange
- IRMD Nasdaq
- ASTH Nasdaq
- Market Cap
- IRMD 910.4M
- ASTH 1.1B
- IPO Year
- IRMD 2014
- ASTH N/A
- Fundamental
- Price
- IRMD $89.74
- ASTH $22.62
- Analyst Decision
- IRMD Strong Buy
- ASTH Strong Buy
- Analyst Count
- IRMD 1
- ASTH 7
- Target Price
- IRMD $72.00
- ASTH $43.86
- AVG Volume (30 Days)
- IRMD 81.0K
- ASTH 622.4K
- Earning Date
- IRMD 11-03-2025
- ASTH 11-06-2025
- Dividend Yield
- IRMD 0.75%
- ASTH N/A
- EPS Growth
- IRMD 13.00
- ASTH N/A
- EPS
- IRMD 1.65
- ASTH 0.20
- Revenue
- IRMD $80,511,268.00
- ASTH $2,896,452,000.00
- Revenue This Year
- IRMD $12.93
- ASTH $60.87
- Revenue Next Year
- IRMD $11.26
- ASTH $27.04
- P/E Ratio
- IRMD $54.74
- ASTH $115.68
- Revenue Growth
- IRMD 12.91
- ASTH 68.17
- 52 Week Low
- IRMD $47.48
- ASTH $20.12
- 52 Week High
- IRMD $91.06
- ASTH $45.16
- Technical
- Relative Strength Index (RSI)
- IRMD 70.99
- ASTH 37.63
- Support Level
- IRMD $82.64
- ASTH $20.12
- Resistance Level
- IRMD $87.26
- ASTH $24.50
- Average True Range (ATR)
- IRMD 2.56
- ASTH 1.93
- MACD
- IRMD 0.15
- ASTH -0.41
- Stochastic Oscillator
- IRMD 88.00
- ASTH 17.96
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.